Showing 811-820 of 18562 results for "".
Current Treatment for Arthritis
https://reachmd.com/programs/clinicians-roundtable/current-treatment-for-arthritis/480/Dr. Patience White, Chief Public Health Officer for the Arthritis Foundation and Professor of Medicine and Pediatrics at the George Washington University School of Medicine and Health Sciences discusses some of the newest treatments on the horizon and how they address the various types of arthritis.Arthritis Prevention
https://reachmd.com/programs/clinicians-roundtable/arthritis-prevention/479/Dr. Patience White, Chief Public Health Officer for the Arthritis Foundation and Professor of Medicine and Pediatrics at the George Washington University School of Medicine and Health Sciences discusses steps that can be taken to prevent the various types of arthritis. She also discusses programs ofDiagnosing Non-Arthritic Hip Pain in Athletes
https://reachmd.com/programs/focus-on-sports-medicine/diagnosing-non-arthritic-hip-pain-in-athletes/3800/In sports medicine, the hip has traditionally received less attention from physicians than other joints. What are the types of non-arthritic hip pain that clinicians need to recognize in order to make accurate diagnoses for both recreational and professional athletes? Dr. Brian Kelly, assistant profIs it Nonresponsive/Progressive ISM?
https://reachmd.com/programs/cme/is-it-nonresponsiveprogressive-ism/32714/Explore 4 case-based episodes for insights on the pathologist’s role in the identification and diagnosis of systemic mastocytosis in the community.Investigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
https://reachmd.com/programs/clinicians-roundtable/investigating-the-potential-link-between-chronic-tonsillitis-and-iga-nephropathy/27026/Dive into a study focused on chronic tonsillitis and its possible link to IgA nephropathy.Mitigating Risk in New IBD Treatments– IBD Pro Webinar Series
https://reachmd.com/programs/cme/mitigating-risk-in-new-ibd-treatments-ibd-pro-webinar-series/16004/Join us for this module of the IBD Pro Webinar Series presentation titled “How to Mitigate Risks in New Therapies”. The talk will include new medications, positioning, real world evidence, and the Foundation's EMR IBD Education Tool. The 45 minute presentation will be followed by a 15 minute quesFertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/fertility-and-safety-of-ibd-medications-during-pregnancy-ibd-pro-webinar-series/16104/Join us for this IBD Pro Webinar Series presentation titled “Fertility and Safety of IBD Medications During Pregnancy”. The talk will include a discussion on fertility in IBD patients and the safety profile of IBD treatments during pregnancy. The 40-minute presentation will be followed by a 20-miEvidence Builds for Cell-Based Influenza Vaccines
https://reachmd.com/programs/medical-industry-feature/evidence-cell-based-influenza-vaccines/36269/Randomized controlled trials have shown data supporting the safety and efficacy of cell-based influenza vaccines in adults and children.1-4 However, effectiveness studies have historically relied on outcomes based on clinical diagnosis of influenza-like illness rather than test-confirmed influenza.5Why Integrating a Wellness Lounge into Your Practice Makes Sense
https://modernaesthetics.com/topics/minimally-invasive/why-integrating-a-wellness-lounge-into-your-practice-makes-sense/35187/First-hand tips from a successful integrationScreening and Prophylaxis for Venous Thromboembolism
https://reachmd.com/programs/advances-in-long-term-care-medicine/screening-and-prophylaxis-for-venous-thromboembolism/5825/Patients who have recently had orthopedic and other types of general surgery, those who have recently had a stroke, and those with an ongoing medical condition (such as heart disease) are at most risk for developing venous thromboembolic disease. Do most long-term care facilities screen for this con